Sleep and daily functioning during androgen deprivation therapy for prostate cancer.
A limited body of evidence suggests that sleep problems are common in prostate cancer patients undergoing androgen deprivation therapy, yet little is known about sleep characteristics and the effects of poor sleep on daily functioning in this population. This study assessed sleep in 60 prostate cancer patients taking androgen deprivation therapy with wrist actigraphy and daily diaries for 7 days. The Epworth Sleepiness Scale and the general version of the Functional Assessment of Cancer Therapy scale were also administered. On average, total sleep time was 5.9 (SD = 1.4) h, and sleep efficiency was 75% (SD = 12.0) as assessed by actigraphy. There was generally poor concordance between actigraphy and daily diary for most sleep metrics. Subjects reported awakening, on average, 2.7 times per night, most commonly for nocturia and hot flashes. Assessment of daily functioning showed that participants had mild daytime sleepiness, which was predicted by total sleep time (F(1,47) = 4.5, P= 0.04) General quality of life was not impaired. This study supports more research on the predictors of poor sleep in order to identify effective interventions.
Hanisch
L J
LJ
Department of Psychiatry, School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. hanisch@mail.med.upenn.edu
Gooneratne
N S
NS
Soin
K
K
Gehrman
P R
PR
Vaughn
D J
DJ
Coyne
J C
JC
D000368:Aged; D000369:Aged, 80 and over; D000726:Androgen Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D019584:Hot Flashes / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D011788:Quality of Life; D012720:Severity of Illness Index; D012893:Sleep Wake Disorders / Q000139:chemically induced*; D011795:Surveys and Questionnaires
D000726:Androgen Antagonists
J Fam Pract. 2002 Mar;51(3):229-35
11978233
J Clin Oncol. 2001 Feb 1;19(3):895-908
11157043
Behav Sleep Med. 2003;1(4):227-47
15600216
J Am Geriatr Soc. 2008 Jul;56(7):1218-27
18482295
Sleep. 2009 Oct;32(10):1367-75
19848365
Sleep. 2004 Feb 1;27(1):158-65
14998254
Sleep. 1992 Aug;15(4):376-81
1519015
Clin Cornerstone. 2003;5(3):5-15
14626537
J Support Oncol. 2009 Jul-Aug;7(4):131-5
19731578
Sleep. 2007 Feb;30(2):213-8
17326547
J Psychosom Res. 2004 May;56(5):503-10
15172206
Sleep Med. 2009 Feb;10(2):233-9
18387848
J Urol. 2006 Dec;176(6 Pt 1):2443-7
17085125
Urology. 2009 Mar;73(3):635-40
19038426
Psychooncology. 2005 Feb;14(2):147-56
15386779
Psychooncology. 2010 Jul;19(7):767-76
19885853
Curr Med Res Opin. 2008 Jan;24(1):307-17
18070379
Sleep. 1999 May 1;22 Suppl 2:S354-8
10394607
J Psychopharmacol. 1999;13(4 Suppl 1):S21-4
10667452
J Cancer Res Clin Oncol. 2008 Dec;134(12):1385-96
18491137
Sleep Med Rev. 2010 Aug;14(4):239-47
19896872
J Psychiatr Res. 2003 Jan-Feb;37(1):9-15
12482465
Chronobiologia. 1979 Oct-Dec;6(4):305-23
548245
Sleep Med Rev. 2010 Aug;14(4):219-26
20363166
J Clin Oncol. 1993 Mar;11(3):570-9
8445433
Health Qual Life Outcomes. 2003 Dec 16;1:79
14678568
Oncol Nurs Forum. 1998 Jan-Feb;25(1):51-62
9460773
BJU Int. 2007 Feb;99(2):301-10
17155990
J Rehabil Res Dev. 2005 May-Jun;42(3):391-9
16187251